Flexion Therapeutics Inc: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2020)
- $85.6M
- Net Income/Loss (FY2020)
- -$113.7M
- Total Assets (FY2020)
- $251.9M
- Total Equity (FY2020)
- -$16.7M
- Cash Flows from Operating Activities (FY2020)
- -$70.6M
Source: Flexion Therapeutics Inc 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
